Company Description
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally.
It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.
It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems.
In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures.
It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers.
The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Country | United States |
| Founded | 1987 |
| IPO Date | Aug 9, 1990 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 6,950 |
| CEO | Fred Lampropoulos |
Contact Details
Address: 1600 West Merit Parkway South Jordan, Utah 84095 United States | |
| Phone | 801 253 1600 |
| Website | merit.com |
Stock Details
| Ticker Symbol | MMSI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000856982 |
| CUSIP Number | 589889104 |
| ISIN Number | US5898891040 |
| Employer ID | 87-0447695 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Fred P. Lampropoulos | Founder, Chief Executive Officer and Chairman |
| Joseph C. Wright | President |
| Raul Parra Jr., CPA | Chief Financial Officer and Treasurer |
| Neil W. Peterson | Chief Operating Officer |
| Brian G. Lloyd J.D. | Chief Legal Officer and Corporate Secretary |
| Jason Treft | Chief Information Officer |
| Sarah Comstock | Vice President of Global Communications |
| JoAnne Alkire | Executive Vice President of Global Marketing and Strategy |
| Michel J. Voigt | Chief Human Resources Officer |
| John Knorpp | Chief Regulatory Affairs Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 15, 2024 | 144 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 144 | Filing |
| Nov 5, 2024 | 144 | Filing |
| Nov 5, 2024 | 144 | Filing |
| Nov 1, 2024 | 8-K | Current Report |
| Oct 30, 2024 | 10-Q | Quarterly Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 18, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |